RecruitingNot ApplicableNCT07291414

A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients

Patient Engagement in Using the Technology for Self-Tracking Medication Safety Events


Sponsor

University of Michigan Rogel Cancer Center

Enrollment

80 participants

Start Date

Jan 9, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This clinical trial evaluates the usefulness of a self-monitoring platform for tracking medication safety events and concerns in patients with lung, colorectal, breast, and prostate cancer. Patients receiving oral anticancer agents often encounter challenges in managing complex treatment regimens, potentially life-threatening toxicities, and drug-drug and drug-food interactions at home. To achieve the goal of medication safety, they need to become "vigilant partners" in medication and toxicity self-monitoring, including timely reporting of medication events to clinicians when their care transitions back home. In this study, patients use an online self-monitoring platform to track their experiences or concerns about taking their medications, including their experiences with symptoms. This platform may be a useful way for patients to track problems they have when taking their medications at home and may help them take better care of their health.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests a digital self-monitoring platform that lets cancer patients track their concerns and experiences with medication safety — such as side effects, missed doses, or drug interactions — in real time between clinic visits. **You may be eligible if...** - You are 18 or older - You have been diagnosed with lung, colorectal, breast, or prostate cancer - You are currently receiving active cancer treatment - You are managing one or more cancer medications yourself - You have access to a smartphone, tablet, or computer (or a family member who can help) - You speak and read English (or have someone to assist) **You may NOT be eligible if...** - You do not have access to technology or the internet - You do not speak or read English and have no one to help - Your healthcare provider does not give permission to participate Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHEREducational Intervention

Receive educational materials and resources

OTHERElectronic Health Record Review

Ancillary studies

PROCEDUREFollow-Up

Receive follow-up contact

OTHERInternet-Based Intervention

Use self-monitoring platform

OTHERInterview

Ancillary studies

OTHERSurvey Administration

Ancillary studies


Locations(1)

University of Michigan Comprehensive Cancer Center

Ann Arbor, Michigan, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07291414


Related Trials